Literature DB >> 3140482

Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia.

J Thiele1, G Schneider, B Hoeppner, S Wienhold, R Zankovich, R Fischer.   

Abstract

A histomorphometric analysis was performed on trephine biopsies of the bone marrow in 55 patients with chronic myeloproliferative disorders (CMPDs) and marked thrombocytosis (platelet count exceeding 600 x 10(9)/l). This study aimed at discriminating primary (essential) thrombocythaemia (PTH) from the various other subtypes of CMPDs presenting with thrombocytosis. Following the diagnostic requirements postulated by the Polycythemia-vera-Study-Group for PTH and polycythaemia vera rubra (P.vera) and the generally accepted criteria for the establishment of chronic myeloid leukaemia (CML) and agnogenic myeloid metaplasia (AMM), our cohort of 55 patients was divided into the following subgroups: CML (16 cases), P.vera (11 cases), AMM (13 cases) and finally PTH (15 cases). Histomorphometric measurements revealed that PTH was distinguishable from the other subtypes of CMPDs with respect to several histological variables: patients with PTH had a normal amount of neutrophilic granulo- and erythrocytopoiesis as well as a non-increased content of reticulin (argyrophilic) fibers in contrast to the findings in CML, P.vera and of course AMM. Moreover, sizes of megakaryocytes and their nuclei were significantly greater in PTH and internalization of haematopoietic cells (emperipolesis) was more frequently encountered in comparison with the other subtypes of CMPDs. Deviation of the circular perimeter of megakaryocyte shape was most prominently expressed in CML and AMM, and consequently generated an increased number of a-nuclear cytoplasmic fragments. In contrast to this feature aberration of the nuclei from a circular outline occurred in a less pronounced way in CML, but was excessive in P.vera, AMM and PTH. Our morphometric evaluation demonstrates that certain histological features may serve as a valuable aid in discriminating PTH from the other occasionally thrombocythaemic subtypes of CMPDs.

Entities:  

Mesh:

Year:  1988        PMID: 3140482     DOI: 10.1007/bf00716989

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  25 in total

1.  Originalarbeiten.

Authors:  W Queisser; G Weidenauer; U Queisser; U Kempgens; U Müller
Journal:  Blut       Date:  1976-01

2.  Essential thrombocythemia: an interim report from the Polycythemia Vera Study Group.

Authors:  S Murphy; H Iland; D Rosenthal; J Laszlo
Journal:  Semin Hematol       Date:  1986-07       Impact factor: 3.851

3.  Cytophotometric study of megakaryocyte ploidy in polycythemia vera and chronic granulocytic leukemia.

Authors:  B Lagerlöf
Journal:  Acta Cytol       Date:  1972 May-Jun       Impact factor: 2.319

4.  Bone marrow biopsy with unaltered architecture: a new biopsy device.

Authors:  K Jamshidi; W R Swaim
Journal:  J Lab Clin Med       Date:  1971-02

Review 5.  New approaches in chronic granulocytic leukemia--origin, prognosis, and treatment.

Authors:  J M Goldman; D P Lu
Journal:  Semin Hematol       Date:  1982-10       Impact factor: 3.851

6.  The relation of platelet kinetics to bone marrow megakaryocytes in chronic granulocytic leukaemia.

Authors:  I Branehög; B Ridell; B Swolin; A Weinfeld
Journal:  Scand J Haematol       Date:  1982-11

Review 7.  The bone marrow in polycythemia vera.

Authors:  J T Ellis; P Peterson
Journal:  Pathol Annu       Date:  1979

8.  Megakaryopoiesis in chronic myeloproliferative diseases. A morphometric evaluation with special emphasis on primary thrombocythemia.

Authors:  J Thiele; S Funke; S Holgado; H Choritz; A Georgii
Journal:  Anal Quant Cytol       Date:  1984-09

9.  Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.

Authors:  P D Berk; J D Goldberg; P B Donovan; S M Fruchtman; N I Berlin; L R Wasserman
Journal:  Semin Hematol       Date:  1986-04       Impact factor: 3.851

10.  Micromegakaryocytes in Human Bone Marrow.

Authors:  M Wiesneth; H Pflieger; B Kubanek; H Heimpel
Journal:  Acta Haematol       Date:  1980       Impact factor: 2.195

View more
  9 in total

1.  Histologic findings in bone marrow biopsies of patients with thrombocythemic cell counts.

Authors:  T Buhr; A Georgii; O Schuppan; A Amor; V Kaloutsi
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

2.  The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states.

Authors:  A W Cashell; D H Buss
Journal:  Ann Hematol       Date:  1992-06       Impact factor: 3.673

Review 3.  Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview.

Authors:  J Thiele; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

Review 4.  Rethinking the diagnostic criteria of polycythemia vera.

Authors:  T Barbui; J Thiele; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2013-12-19       Impact factor: 11.528

5.  Summary and Review of the Abstracts on Philadelphia-Negative Myeloproliferative Neoplasms Presented at Haematocon 2017.

Authors:  Tathagata Chatterjee; Ankur Ahuja
Journal:  Indian J Hematol Blood Transfus       Date:  2018-02-03       Impact factor: 0.900

Review 6.  Is it justified to perform a bone marrow biopsy examination in sustained erythrocytosis?

Authors:  Juergen Thiele; Hans Michael Kvasnicka
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

Review 7.  Megakaryocytes as immune cells.

Authors:  Pierre Cunin; Peter A Nigrovic
Journal:  J Leukoc Biol       Date:  2019-01-15       Impact factor: 4.962

8.  Nucleolar organizer regions of megakaryocytes in chronic myeloproliferative disorders.

Authors:  A Matolcsy; R Nádor; E Wéber; T Kónya
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

9.  Emperipolesis of marrow cells within megakaryocytes in the bone marrow of sublethally irradiated mice.

Authors:  R Bobik; Z Dabrowski
Journal:  Ann Hematol       Date:  1995-02       Impact factor: 3.673

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.